RecallGuardianCanada
Drugs· Updated September 1, 2001

Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc.

Critical priority
Where it was sold

ONReported in the official notice — confirm there.

Issued by

Health Canada — Marketed health products

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls
Archived - Conditional Approval Of Gleevec (Imatinib) - Novartis Pharma Canada Inc. — recall · RecallGuardian